当前位置: X-MOL 学术Blood › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trial
Blood ( IF 21.0 ) Pub Date : 2017-09-21 , DOI: 10.1182/blood-2017-04-775841
Isabelle Krämer 1 , Stephan Stilgenbauer 2 , Sascha Dietrich 1 , Sebastian Böttcher 3, 4 , Matthias Zeis 5 , Michael Stadler 6 , Jörg Bittenbring 7 , Lutz Uharek 8 , Christof Scheid 9 , Ute Hegenbart 1 , Anthony Ho 1 , Michael Hallek 9 , Michael Kneba 3 , Norbert Schmitz 5 , Hartmut Döhner 2 , Peter Dreger 1
Affiliation  

1 Department of Medicine V, University of Heidelberg 2 Department of Medicine III, University of Ulm 3 Department of Medicine II, University of Schleswig-Holstein 4 Department of Medicine III, University Medical Center Rostock 5 Department of Hematology, Oncology and Stem Cell Transplantation, Asklepios Hospital St. Georg 6 Department of Hematology Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School 7 Department of Internal Medicine I, Saarland University Medical School 8 Division of Hematology, Oncology and Tumor Immunology, Charité University Medicine Berlin 9 Department of Medicine I, University of Cologne

中文翻译:

高危 CLL 的异基因造血细胞移植:GCLLSG CLL3X 试验的 10 年随访

1 海德堡大学医学 V 系 2 乌尔姆大学医学 III 系 3 石勒苏益格-荷尔斯泰因大学医学 II 系 4 罗斯托克大学医学中心医学 III 系 5 血液学、肿瘤学和干细胞移植系, Asklepios 医院 St. Georg 6 血液学系 汉诺威医学院止血、肿瘤学和干细胞移植 7 内科 I,萨尔大学医学院 8 血液学、肿瘤学和肿瘤免疫学系,查理特大学医学院 9 医学 I 系, 科隆大学
更新日期:2017-09-21
down
wechat
bug